Reference health

Clinical Characteristics and Risk Factors for COVID-19 Infection and Disease Severity: A Nationwide Observational Study in Estonia

https://doi.org/10.2139/ssrn.3955730
CiteStamped reference-health badge
36/36 checkable references clean · checked 2026-08-29

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

29 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 36 checked references that resolve
resolves10.1056/NEJMoa2002032
Clinical Characteristics of Coronavirus Disease 2019 in China
resolves10.1016/S0140-6736(20)31482-3
SARS-CoV-2 seroprevalence in COVID-19 hotspots
resolves10.1038/d41586-020-01003-6
Special report: The simulations driving the world’s response to COVID-19
resolves10.1016/S1473-3099(20)30371-6
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
resolves10.1136/bmjopen-2020-044640
Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies
resolves10.1371/journal.pmed.1003321
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
resolves10.1038/s41746-021-00383-x
Predicting COVID-19 mortality with electronic medical records
resolves10.1038/s41591-020-01191-8
Individual and community-level risk for COVID-19 mortality in the United States
resolves10.1038/s41586-020-2521-4
Factors associated with COVID-19-related death using OpenSAFELY
resolves10.1056/NEJMp2002125
Defining the Epidemiology of Covid-19 — Studies Needed
resolves10.1136/oem.2004.014472
An incidence density sampling program for nested case-control analyses
resolves10.1016/0021-9681(87)90171-8
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
resolves10.1001/jamanetworkopen.2020.12270
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit
resolves10.1001/jamainternmed.2020.3539
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
resolves10.1016/j.vaccine.2019.10.005
Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season
resolves10.1093/aje/kwq433
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
resolves10.15585/mmwr.mm7009a4
Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020
resolves10.1038/s41467-021-21100-y
The natural history of symptomatic COVID-19 during the first wave in Catalonia
resolves10.1002/wps.20806
Increased risk of <scp>COVID</scp> ‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
resolves10.1002/alz.12296
COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
resolves10.1371/journal.pone.0241827
COVID-19 gender susceptibility and outcomes: A systematic review
resolves10.1053/j.ajkd.2007.11.022
Expression of ACE and ACE2 in Individuals With Diabetic Kidney Disease and Healthy Controls
resolves10.1038/ki.2008.497
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease
resolves10.1159/000324521
Expression of ACE and ACE2 in Patients with Hypertensive Nephrosclerosis
resolves10.1016/j.immuni.2020.04.003
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
resolves10.1371/journal.pone.0255541
Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients
resolves10.1038/s41598-021-83641-y
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
resolves10.1016/j.ebiom.2021.103403
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
resolves10.1093/infdis/jiu159
Sex Differences in Infectious Diseases-Common but Neglected
resolves10.4049/jimmunol.1601166
Sex Drives Dimorphic Immune Responses to Viral Infections
resolves10.1093/infdis/jit610
Sex Bias in the Outcome of Human Tropical Infectious Diseases: Influence of Steroid Hormones
resolves10.1093/infdis/jiu147
Biological Differences Between the Sexes and Susceptibility to Tuberculosis
resolves10.1093/infdis/jiu175
Sex-Based Differences in HIV Type 1 Pathogenesis
resolves10.1073/pnas.2003138117
Cell entry mechanisms of SARS-CoV-2
resolves10.1097/MNH.0b013e328341164a
Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease
resolves10.1038/s41591-021-01410-w
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
The 29 references without a DOI — listed, not checked
no DOI — not checkedref1
no DOI — not checkedref2
no DOI — not checkedref3
no DOI — not checkedFeatures of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
no DOI — not checkedref6
no DOI — not checkedref9
no DOI — not checkedEstonia: Health system review
no DOI — not checkedref18
no DOI — not checkedref19
no DOI — not checkedref20
no DOI — not checkedref21
no DOI — not checkedref23
no DOI — not checkedref24
no DOI — not checkedFactors associated with hospital admission and critical illness among 5279 people with coronavirus disease
no DOI — not checkedref29
no DOI — not checkedref30
no DOI — not checkedref33
no DOI — not checkedref34
no DOI — not checkedref35
no DOI — not checkedref37
no DOI — not checkedHousehold Transmission of SARS-CoV-2 in the United States
no DOI — not checkedref39
no DOI — not checkedChronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
no DOI — not checkedref49
no DOI — not checkedref53
no DOI — not checkedref59
no DOI — not checkedExcess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics
no DOI — not checkedPrevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)
no DOI — not checkedref64
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-29 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.3955730"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3955730/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.3955730/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.3955730)